SEC Filing | Company/Stock | Trade Date | Transaction | Shares | Avg. Price | Total | % Holdings | Gain/Loss |
---|---|---|---|---|---|---|---|---|
20-Jun-24 5:03 PM View: | Pacific Biosciences Of Cali... (PACB) | 18-Jun-24 | Grant | 22,821 | -- | -- | 100% 0 to 22.82K | |
17-Feb-21 9:19 PM View: | Pacific Biosciences Of Cali... (PACB) | 12-Feb-21 | Private Sale | 101,666 | $50.40 | $5,123,970.00 | (100%) 101.67K to 0 | |
24-Jun-16 3:04 PM View: | Anacor Pharmaceuticals, Inc. (ANAC) | 24-Jun-16 | Disposition | 794 | $99.25 | $78,804.50 | (100%) 0.79K to 0 | |
26-Jan-16 4:01 PM View: | Pacific Biosciences Of Cali... (PACB) | 22-Jan-16 | Option Exercise | 101,666 | $3.33 | $338,796.00 | 100% 0 to 101.67K | |
11-Jun-15 7:45 PM View: | Anacor Pharmaceuticals, Inc. (ANAC) | 09-Jun-15 | Grant | 794 | -- | -- | 100% 0 to 0.79K | |
29-Dec-14 4:05 PM View: | Anacor Pharmaceuticals, Inc. (ANAC) | 24-Dec-14 | Gift | 28,000 | -- | -- | (100%) 28.0K to 0 | |
12-Dec-14 6:49 PM View: | Anacor Pharmaceuticals, Inc. (ANAC) | 12-Dec-14 | Market Sale | 44,384 | $34.45 | $1,528,870.00 | (57%) 77.83K to 33.45K | (106%) |
12-Dec-14 6:49 PM View: | Anacor Pharmaceuticals, Inc. (ANAC) | 12-Dec-14 | Market Sale | 5,447 | $34.48 | $187,813.00 | (16%) 33.45K to 28.0K | (106%) |
12-Dec-14 6:49 PM View: | Anacor Pharmaceuticals, Inc. (ANAC) | 11-Dec-14 | Market Sale | 30,801 | $34.91 | $1,075,180.00 | (13%) 228.66K to 197.86K | (103%) |
12-Dec-14 6:49 PM View: | Anacor Pharmaceuticals, Inc. (ANAC) | 11-Dec-14 | Market Sale | 120,032 | $34.92 | $4,191,880.00 | (61%) 197.86K to 77.83K | (103%) |
12-Dec-14 6:49 PM View: | Anacor Pharmaceuticals, Inc. (ANAC) | 10-Dec-14 | Option Exercise | 89,021 | $6.95 | $618,971.00 | 39% 228.66K to 317.69K | |
12-Dec-14 6:49 PM View: | Anacor Pharmaceuticals, Inc. (ANAC) | 10-Dec-14 | Market Option Sale | 89,021 | $35.79 | $3,185,740.00 | (28%) 317.69K to 228.66K | (98%) |
25-Mar-14 4:59 PM View: | Anacor Pharmaceuticals, Inc. (ANAC) | 21-Mar-14 | Market Sale | 80,000 | $21.14 | $1,691,390.00 | (26%) 308.66K to 228.66K | (236%) |
19-Apr-13 9:00 PM View: | Anacor Pharmaceuticals, Inc. (ANAC) | 19-Apr-13 | Market Sale (Planned) | 25,000 | $8.02 | $200,400.00 | (7%) 333.66K to 308.66K | (785%) |
22-Mar-13 7:32 PM View: | Anacor Pharmaceuticals, Inc. (ANAC) | 22-Mar-13 | Market Sale (Planned) | 20,000 | $6.91 | $138,200.00 | (6%) 353.66K to 333.66K | (927%) |
05-Oct-12 5:35 PM View: | Anacor Pharmaceuticals, Inc. (ANAC) | 05-Oct-12 | Market Sale (Planned) | 15,000 | $6.66 | $99,898.50 | (4%) 368.66K to 353.66K | (965%) |
05-Oct-12 5:35 PM View: | Anacor Pharmaceuticals, Inc. (ANAC) | 03-Oct-12 | Market Sale (Planned) | 15,000 | $6.68 | $100,275.00 | (4%) 383.66K to 368.66K | (961%) |
01-Oct-12 7:53 PM View: | Anacor Pharmaceuticals, Inc. (ANAC) | 01-Oct-12 | Market Sale (Planned) | 14,400 | $6.54 | $94,125.60 | (4%) 398.06K to 383.66K | (985%) |
01-Oct-12 7:53 PM View: | Anacor Pharmaceuticals, Inc. (ANAC) | 28-Sep-12 | Market Sale (Planned) | 5,600 | $6.65 | $37,224.30 | (1%) 403.66K to 398.06K | (967%) |
28-Sep-12 2:20 PM View: | Anacor Pharmaceuticals, Inc. (ANAC) | 26-Sep-12 | Market Sale (Planned) | 10,000 | $6.58 | $65,800.00 | (2%) 413.66K to 403.66K | (978%) |
24-Sep-12 5:25 PM View: | Anacor Pharmaceuticals, Inc. (ANAC) | 24-Sep-12 | Market Sale (Planned) | 10,000 | $6.35 | $63,540.00 | (2%) 423.66K to 413.66K | (1017%) |
24-Sep-12 5:25 PM View: | Anacor Pharmaceuticals, Inc. (ANAC) | 21-Sep-12 | Market Sale (Planned) | 10,000 | $6.30 | $62,960.00 | (2%) 433.66K to 423.66K | (1027%) |
02-Aug-12 4:47 PM View: | Gen-Probe Inc. (GPRO) | 01-Aug-12 | Disposition | 1,126 | $82.75 | $93,176.50 | (100%) 1.13K to 0 | |
04-Apr-12 5:23 PM View: | Gen-Probe Inc. (GPRO) | 02-Apr-12 | Grant | 48 | $67.26 | $3,228.48 | 4% 1.08K to 1.13K | (91%) |
05-Jan-12 5:39 PM View: | Gen-Probe Inc. (GPRO) | 03-Jan-12 | Grant | 55 | $58.93 | $3,241.15 | 5% 1.02K to 1.08K | (90%) |
05-Oct-11 4:44 PM View: | Gen-Probe Inc. (GPRO) | 03-Oct-11 | Grant | 240 | $55.04 | $13,209.60 | 31% 0.78K to 1.02K | (89%) |
06-Jul-11 5:24 PM View: | Gen-Probe Inc. (GPRO) | 01-Jul-11 | Grant | 46 | $69.79 | $3,210.34 | 6% 0.74K to 0.78K | (91%) |
05-Apr-11 4:16 PM View: | Gen-Probe Inc. (GPRO) | 01-Apr-11 | Grant | 49 | $66.06 | $3,236.94 | 7% 0.69K to 0.74K | (91%) |
05-Jan-11 3:23 PM View: | Gen-Probe Inc. (GPRO) | 03-Jan-11 | Grant | 54 | $59.40 | $3,207.60 | 9% 0.63K to 0.69K | (90%) |
01-Dec-10 6:06 PM View: | Anacor Pharmaceuticals, Inc. (ANAC) | 30-Nov-10 | Conversion | 29,582 | -- | -- | 7% 440.17K to 469.75K | |
01-Dec-10 6:06 PM View: | Anacor Pharmaceuticals, Inc. (ANAC) | 30-Nov-10 | Conversion | 15,250 | -- | -- | 3% 469.75K to 485.0K | |
05-Oct-10 6:29 PM View: | Gen-Probe Inc. (GPRO) | 01-Oct-10 | Grant | 66 | -- | -- | 12% 0.57K to 0.63K | |
06-Jul-10 4:24 PM View: | Gen-Probe Inc. (GPRO) | 01-Jul-10 | Grant | 71 | -- | -- | 14% 0.5K to 0.57K | |
05-Apr-10 4:06 PM View: | Gen-Probe Inc. (GPRO) | 01-Apr-10 | Grant | 63 | -- | -- | 15% 0.43K to 0.5K | |
06-Jan-10 2:37 PM View: | Gen-Probe Inc. (GPRO) | 04-Jan-10 | Grant | 69 | -- | -- | 19% 0.36K to 0.43K | |
05-Oct-09 5:05 PM View: | Gen-Probe Inc. (GPRO) | 01-Oct-09 | Grant | 73 | -- | -- | 25% 0.29K to 0.36K | |
06-Jul-09 4:20 PM View: | Gen-Probe Inc. (GPRO) | 01-Jul-09 | Grant | 69 | -- | -- | 31% 0.22K to 0.29K | |
03-Apr-09 4:31 PM View: | Gen-Probe Inc. (GPRO) | 01-Apr-09 | Grant | 67 | -- | -- | 43% 0.16K to 0.22K | |
06-Jan-09 12:31 PM View: | Gen-Probe Inc. (GPRO) | 02-Jan-09 | Grant | 69 | -- | -- | 79% 87 to 0.16K | |
03-Oct-08 3:04 PM View: | Gen-Probe Inc. (GPRO) | 01-Oct-08 | Grant | 55 | -- | -- | 172% 32 to 87 | |
03-Jul-08 1:29 PM View: | Gen-Probe Inc. (GPRO) | 01-Jul-08 | Grant | 32 | -- | -- | 100% 0 to 32 |